Isoflurane USP 99.9 % (Isoflurane LIQUID) 99.9 %

ISOFLURANE USP 99.9% is a high-purity inhalation anesthetic liquid used for general anesthesia. This product by Fresenius Kabi Canada Ltd. is designed for controlled administration in clinical settings.

Strength

99.9 %

Pack Size

100/250ML

Manufacturer / TM Owner

FRESENIUS KABI CANADA LTD

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

ISOFLURANE USP 99.9% is primarily used for inducing and maintaining general anesthesia. It is administered via inhalation and is commonly employed in surgical procedures to ensure patient comfort and unconsciousness. This anesthetic is known for its rapid onset and adjustable depth of anesthesia, making it suitable for a variety of medical interventions.

Side Effects

When administered, ISOFLURANE USP 99.9% works by depressing the central nervous system, leading to a state of unconsciousness. Patients typically experience a loss of awareness and sensation, which is crucial for surgical procedures. The effects are carefully monitored to ensure patient safety and comfort throughout the procedure.

Precautions & Warnings

ISOFLURANE USP 99.9% should be handled with care, as it is a potent anesthetic. It should only be used by trained medical professionals in controlled environments. Proper ventilation and monitoring equipment are essential during its administration to manage any potential adverse reactions.

Avoid Interactions

ISOFLURANE USP 99.9% may interact with other medications, particularly those that also affect the central nervous system. It is important to inform healthcare providers of all current medications to avoid potential interactions. Additionally, certain medical conditions may affect the safety and efficacy of this anesthetic, so a thorough patient history is crucial.

Frequently Asked Questions

ISOFLURANE USP 99.9% is used for inducing and maintaining general anesthesia during surgical procedures.

ISOFLURANE USP 99.9% is administered via inhalation, typically using specialized anesthesia equipment.

The common effects include unconsciousness and loss of sensation, which are necessary for surgical procedures.

Only trained medical professionals should handle and administer ISOFLURANE USP 99.9%.

Proper ventilation and monitoring equipment are essential during its administration to manage any potential adverse reactions.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.